These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31646666)

  • 21. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
    Liang Y; Zhang C; Dai DQ
    World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.
    Volinia S; Croce CM
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7413-7. PubMed ID: 23589849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer.
    Tuly KF; Hossen MB; Islam MA; Kibria MK; Alam MS; Harun-Or-Roshid M; Begum AA; Hasan S; Mahumud RA; Mollah MNH
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893423
    [No Abstract]   [Full Text] [Related]  

  • 24. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.
    Zhao Y; Wang Y; Zhu F; Zhang J; Ma X; Zhang D
    Clin Exp Med; 2020 May; 20(2):249-259. PubMed ID: 31980982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer.
    Zhang Y; Gao Y; Li Y; Zhang X; Xie H
    Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
    Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
    Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of Prognostic Factors in Early-Onset Breast Cancer.
    Yu Z; He Q; Xu G
    Technol Cancer Res Treat; 2020; 19():1533033819893670. PubMed ID: 32028860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
    Chen G; Wang Y; Wang L; Xu W
    Oncotarget; 2017 Jan; 8(3):5268-5280. PubMed ID: 28029655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
    Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
    J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG methylation signature predicts prognosis in breast cancer.
    Du T; Liu B; Wang Z; Wan X; Wu Y
    Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
    Xu W; Wang Y; Wang Y; Lv S; Xu X; Dong X
    Int J Mol Med; 2019 Aug; 44(2):390-404. PubMed ID: 31198978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
    Dong M; Yang Z; Li X; Zhang Z; Yin A
    Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
    Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
    J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of alternative splicing events and prognostic signatures in breast cancer.
    Han P; Zhu J; Feng G; Wang Z; Ding Y
    BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
    Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
    Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.